Sartorius AG (XTER:SRT3) EPS (Basic): €3.26 (TTM As of Mar. 2026)


XTER:SRT3 Sartorius AG XTER:SRT3
83 GF Score
Price €219.40
GF Value €256.36
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Sartorius AG EPS (Basic)?

Sartorius AG XTER:SRT3 +3.15% 83 EPS (Basic) is €3.26 as of Mar. 2026. GuruFocus rates XTER:SRT3 with a GF Score™ of 83/100 and a GF Value™ of €256.36 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Sartorius AG's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was €0.81. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was €3.26.

Sartorius AG's EPS (Diluted) for the three months ended in Mar. 2026 was €0.81. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €3.26.

Sartorius AG's EPS without NRI for the three months ended in Mar. 2026 was €0.81. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 3.26.

During the past 12 months, Sartorius AG's average EPS without NRIGrowth Rate was 72.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was -33.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was -18.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 7.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Sartorius AG's highest 3-Year average EPS without NRI Growth Rate was 92.00% per year. The lowest was -35.90% per year. And the median was 20.00% per year.

Sartorius AG  (XTER:SRT3) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Sartorius AG EPS (Basic) Related Terms

Sartorius AG EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Sartorius AG's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius AG EPS (Basic) Chart

Sartorius AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.66 9.91 3.00 1.21 2.24

Sartorius AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.70 0.47 0.63 1.35 0.81
XTER:SRT3
83GF Score
Sartorius AG XTER:SRT3
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sartorius AG EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Sartorius AG's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(154.9-0)/69.045
=2.24

Sartorius AG's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(56.2-0)/69.383
=0.81

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €3.26 mean?
Sartorius AG (XTER:SRT3) has a EPS (Basic) of €3.26 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Sartorius AG and its competitors.
Is Sartorius AG's EPS (Basic) too high?
Sartorius AG's current EPS (Basic) is €3.26. Overall, Sartorius AG has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sartorius AG's EPS (Basic) compare to ISRG and BDX?
Sartorius AG's EPS (Basic) of €3.26 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Sartorius AG and its competitors. Sartorius AG's current EPS (Basic) is €3.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius AG stock overvalued right now?
Based on GuruFocus' analysis, Sartorius AG (XTER:SRT3) is currently considered Modestly Undervalued. The stock's GF Value™ is €256.36, compared to a current price of €219.40 — trading 14.4% below its estimated fair value. The current EPS (Basic) is €3.26. Sartorius AG's overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Sartorius AG (XTER:SRT3), the current EPS (Basic) is €3.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sartorius AG (XTER:SRT3) Overvalued in 2026?

Based on GuruFocus' analysis, Sartorius AG stock appears to be undervalued. The current stock price of €219.40 is trading 14.4% below its estimated GF Value™ of €256.36. GuruFocus considers Sartorius AG to be Modestly Undervalued.

Key valuation signals for XTER:SRT3:

  • EPS (Basic): €3.26
  • GF Value™: €256.36 vs. price of €219.40 (14.4% below fair value)
  • GF Score™: 83/100 with 6 warning signs

No single metric tells the full story. See the XTER:SRT3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sartorius AG Business Description

Address Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs and focuses on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.
83GF Score

Get the complete analysis for XTER:SRT3

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€219.40
Price
€256.36
GF Value